Which of the following is NOT listed as an MRSA treatment option in the material?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the NBEO Part II TMOD Exam. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam!

Multiple Choice

Which of the following is NOT listed as an MRSA treatment option in the material?

Explanation:
MRSA treatment choices focus on antibiotics with reliable activity against MRSA and good clinical relevance. In the material, agents like clindamycin, trimethoprim-sulfamethoxazole (Bactrim), and doxycycline are listed as MRSA options because they have demonstrated MRSA activity and are commonly used in practice. Moxifloxacin, a fluoroquinolone, generally does not have consistent MRSA activity and is not considered a standard MRSA option in the material due to resistance concerns and limited proven efficacy. That’s why it’s the one not listed.

MRSA treatment choices focus on antibiotics with reliable activity against MRSA and good clinical relevance. In the material, agents like clindamycin, trimethoprim-sulfamethoxazole (Bactrim), and doxycycline are listed as MRSA options because they have demonstrated MRSA activity and are commonly used in practice. Moxifloxacin, a fluoroquinolone, generally does not have consistent MRSA activity and is not considered a standard MRSA option in the material due to resistance concerns and limited proven efficacy. That’s why it’s the one not listed.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy